Infographic: Biosimilar Trastuzumab

October 22, 2017
The Center for Biosimilars Staff

Data from 5 studies presented at the European Society for Medical Oncology (ESMO) 2017 meeting highlighted the progress of biosimilar trastuzumab candidates.

Data from 5 studies presented at the European Society for Medical Oncology (ESMO) 2017 meeting highlighted the progress of biosimilar trastuzumab candidates.

Related Content:

News | Oncology

x